TreeHouse Foods, Inc. Reports Third Quarter 2024 Results
Achieves Expected Supply Chain Savings
Updates 2024 Outlook
- Net sales were
$839.1 million . Excluding the voluntary griddle product recall, adjusted net sales were$854.4 million . - Net loss from continuing operations was
$(3.4) million . - Adjusted EBITDA1 of
$102.5 million was within the Company's guidance range of$98 to$108 million . - Updated 2024 outlook now calls for adjusted net sales of
$3.37 to$3.40 billion , adjusted EBITDA of$335 to$345 million , and free cash flow2 of at least$120 million .
"Our third quarter results were mixed, as a tough operating environment with softer consumer takeaway led to sales below our expectations. However, I was pleased with our supply chain savings, which led to margin improvement and profit that was within our guidance range," said
THIRD QUARTER 2024 FINANCIAL RESULTS
Net Sales — Net sales for the third quarter of 2024 totaled
|
|
Three Months |
|
Nine Months |
|
|
(unaudited) |
|
(unaudited) |
Product recall returns |
|
(1.4) % |
|
(0.6) % |
Volume/mix |
|
(0.8) |
|
(1.5) |
Pricing |
|
(0.5) |
|
(2.0) |
Facility restoration impact |
|
— |
|
(1.0) |
Total change in organic net sales1 |
|
(2.7) % |
|
(5.1) % |
Foreign currency |
|
(0.1) |
|
(0.1) |
Business acquisitions |
|
— |
|
2.3 |
Total change in net sales |
|
(2.8) % |
|
(2.9) % |
The net sales decrease of 2.8% was primarily due to a voluntary recall of frozen griddle products. Additionally, unfavorable volume/mix performance was negatively impacted by approximately
Gross Profit — Gross profit as a percentage of net sales was 15.6% in the third quarter of 2024, compared to 15.9% in the third quarter of 2023, a decrease of 0.3 percentage points. The decrease in Gross profit is primarily due to a voluntary recall of frozen griddle products, which impacted Gross profit by 3.2 percentage points. Adjusted gross profit1 as a percentage of adjusted net sales was 18.9% in the third quarter of 2024, compared to 17.3% in the third quarter of 2023, an increase of 1.6 percentage points. The increase in Adjusted gross profit was primarily due to the execution of supply chain initiatives.
Total Operating Expenses — Total operating expenses were
Total Other Expense — Total other expense was
Income Taxes — Income taxes were recognized at an effective rate of 20.9% in the third quarter of 2024 compared to 27.4% recognized in the third quarter of 2023. The change in the Company's effective tax rate is primarily driven by changes in the amounts of executive compensation that is not deductible for tax purposes, the research and development tax credit, and the effect of cross-border tax laws.
Net (Loss) Income from Continuing Operations and Adjusted EBITDA — Net loss from continuing operations for the third quarter of 2024 was
Discontinued Operations — Net loss from discontinued operations decreased by
OUTLOOK2
- We now expect adjusted net sales in the range of
$3.37 to$3.40 billion , which represents approximately -2% to -1% year-over-year, and reflects weakening consumption trends as well as the estimated impact from the voluntary griddle recall.
- We are updating our expectations for adjusted EBITDA to a range of
$335 to$345 million . This reflects weakening consumption trends and softer mix, which creates deleverage in our supply chain, as well as the estimated impact from the voluntary griddle recall. The Company continues to expect sequential improvement in adjusted EBITDA, driven by the following:- Net sales improvement due to new distribution wins
- Cost savings initiatives
- Our return to normalized service levels in our Broth business
- Net interest expense is continued to be expected in the range of
$56 to$62 million .
- The Company continues to expect capital expenditures of approximately
$145 million .
- The Company now expects free cash flow of at least
$120 million .
With regard to the fourth quarter,
- Fourth quarter adjusted net sales are expected in a range of
$900 to$930 million , which represents approximately -1% to 2% growth year-over-year. Organic volume and mix are expected to be up low-single digits. Pricing is expected to be a slight drag.
- Fourth quarter adjusted EBITDA from continuing operations is expected in a range of
$116 to$126 million .
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Adjusted EBITDA, adjusted gross profit, adjusted net sales, free cash flow, and organic net sales are non-GAAP financial measures. See "Comparison of Non-GAAP Information to GAAP Information" for the definitions of the Non-GAAP measures, information concerning certain items affecting comparability, and reconciliations of GAAP to Non-GAAP measures. |
|||||||||||||||||||
|
|||||||||||||||||||
2 The Company is not able to reconcile prospective adjusted net sales, adjusted EBITDA from continuing operations or free cash flow, which are Non-GAAP financial measures, to the most comparable GAAP financial measures without unreasonable effort due to the inherent uncertainty and difficulty of predicting the occurrence, financial impact, and timing of certain items impacting GAAP results. These items include, but are not limited to, mark-to-market adjustments of derivative contracts, foreign currency exchange on the re-measurement of intercompany notes, or other non-recurring events or transactions that may significantly affect reported GAAP results. |
CONFERENCE CALL WEBCAST
A webcast to discuss the Company's third quarter earnings will be held at
DISCONTINUED OPERATIONS
On
On
COMPARISON OF NON-GAAP INFORMATION TO GAAP INFORMATION
The Company has included in this release measures of financial performance that are not defined by GAAP ("Non-GAAP"). A Non-GAAP financial measure is a numerical measure of financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP in the Company's Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Comprehensive (Loss) Income, Condensed Consolidated Statements of Stockholders' Equity, and the Condensed Consolidated Statements of Cash Flows. As described further below, the Company believes these measures provide useful information to the users of the financial statements.
For each of these Non-GAAP financial measures, the Company provides a reconciliation between the most directly comparable GAAP measure and the Non-GAAP measure, an explanation of why management believes the Non-GAAP measure provides useful information to financial statement users, and any additional purposes for which management uses the Non-GAAP measure. This Non-GAAP financial information is provided as additional information for the financial statement users and is not in accordance with, or an alternative to, GAAP. These Non-GAAP measures may be different from similar measures used by other companies.
Organic
Organic net sales is defined as net sales excluding the impacts of business acquisitions, divestitures, and foreign currency. This information is provided in order to allow investors to make meaningful comparisons of the Company's sales between periods and to view the Company's business from the same perspective as Company management.
EBITDA from Continuing Operations, EBITDA from Continuing Operations Margin, Adjusted EBITDA from Continuing Operations, and Adjusted EBITDA from Continuing Operations Margin, Adjusting for Certain Items Affecting Comparability
EBITDA from continuing operations margin is defined as EBITDA from continuing operations as a percentage of net sales. Adjusted EBITDA from continuing operations margin is defined as adjusted EBITDA from continuing operations as a percentage of adjusted net sales. EBITDA from continuing operations represents net (loss) income from continuing operations before interest expense, interest income, income tax (benefit) expense, and depreciation and amortization expense. Adjusted EBITDA from continuing operations reflects adjustments to EBITDA from continuing operations to identify items that, in management's judgment, significantly affect the assessment of earnings results between periods. This information is provided in order to allow investors to make meaningful comparisons of the Company's earnings performance between periods and to view the Company's business from the same perspective as Company management. As the Company cannot predict the timing and amount of charges that include, but are not limited to, items such as product recalls and related costs, growth, reinvestment, and restructuring programs, acquisition, integration, divestiture, and related costs, impairment of assets, foreign currency exchange impact on the re-measurement of intercompany notes, mark-to-market adjustments on derivative contracts, and other items that may arise from time to time that would impact comparability, management does not consider these costs when evaluating the Company's performance, when making decisions regarding the allocation of resources, in determining incentive compensation, or in determining earnings estimates. EBITDA from continuing operations, and adjusted EBITDA from continuing operations are performance measures commonly used by management to assess operating performance and incentive compensation, and the Company believes they are commonly reported and widely used by investors and other interested parties as a measure of a company's operating performance between periods and as a component of our debt covenant calculations.
Adjusted
Adjusted net sales, adjusted cost of sales, adjusted gross profit, adjusted total operating expenses, adjusted operating (loss) income, adjusted total other expense (income), adjusted income tax expense (benefit), and adjusted net (loss) income from continuing operations represent their respective GAAP presentation line item adjusted for items such as product recalls and related costs, growth, reinvestment, and restructuring programs, acquisition, integration, divestiture, and related costs, impairment of assets, foreign currency exchange impact on the re-measurement of intercompany notes, mark-to-market adjustments on derivative contracts, and other items that may arise from time to time that would impact comparability. Management does not consider these costs when evaluating the Company's performance, when making decisions regarding the allocation of resources, in determining incentive compensation, or in determining earnings estimates. This information is provided in order to allow investors to make meaningful comparisons of the Company's earnings performance between periods and to view the Company's business from the same perspective as Company management. The Company has presented each of these adjusted Non-GAAP measures as a percentage of adjusted net sales compared to its respective reported GAAP presentation line item as a percentage of net sales. Adjusted diluted earnings (loss) per share from continuing operations ("Adjusted diluted EPS") is determined by dividing adjusted net (loss) income from continuing operations by the weighted average diluted common shares outstanding. Adjusted diluted EPS reflects adjustments to GAAP earnings (loss) per diluted share to identify items that, in management's judgment, significantly affect the assessment of earnings results between periods.
A full reconciliation between the relevant GAAP measure of reported net income (loss) from continuing operations for the three and nine months ended
Free Cash Flow from Continuing Operations
In addition to measuring the Company's cash flow generation and usage based upon the operating, investing, and financing classifications included in the Condensed Consolidated Statements of Cash Flows, we also measure free cash flow from continuing operations, which represents net cash used in operating activities from continuing operations less capital expenditures. The Company believes free cash flow is an important measure of liquidity because it provides management and investors a measure of cash generated from operations that is available for mandatory payment obligations and investment opportunities such as funding acquisitions, repaying debt, repurchasing public debt, and repurchasing common stock. A reconciliation between the relevant GAAP measure of cash used in operating activities from continuing operations for the nine months ended
ABOUT
Additional information, including TreeHouse's most recent statements on Forms 10-Q and 10-K, may be found at TreeHouse's website, http://www.treehousefoods.com.
FORWARD-LOOKING STATEMENTS
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements and other information are based on our beliefs, as well as assumptions made by us, using information currently available. The words "believe," "estimate," "project," "expect," "anticipate," "plan," "intend," "foresee," "should," "would," "could," and similar expressions, as they relate to us, are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, or intended. We do not intend to update these forward-looking statements following the date of this press release. Such forward-looking statements, because they relate to future events, are by their very nature subject to many important factors that could cause actual results to differ materially from those contemplated by the forward-looking statements contained in this press release and other public statements we make. Such factors include, but are not limited to: risks related to quality issues, disruptions, or inefficiencies in our supply chain and/or operations; loss or consolidation of key suppliers; raw material and commodity costs due to inflation; labor strikes or work stoppages; multiemployer pension plans; labor shortages and increased competition for labor; success of our growth, reinvestment, and restructuring programs; our level of indebtedness and related obligations; disruptions in the financial markets; interest rates; changes in foreign currency exchange rates; customer concentration and consolidation; competition; our ability to execute on our business strategy; our ability to continue to make acquisitions and execute on divestitures or effectively manage the growth from acquisitions; impairment of goodwill or long lived assets; changes and developments affecting our industry, including customer preferences and the prevalence of weight loss drugs; the outcome of litigation and regulatory proceedings to which we and/or our customers may be a party; product recalls; changes in laws and regulations applicable to us; shareholder activism; disruptions in or failures of our information technology systems; geopolitical events; changes in weather conditions, climate changes, and natural disasters; and other risks that are set forth in the Risk Factors section, the Legal Proceedings section, the Management's Discussion and Analysis of Financial Condition and Results of Operations section, and other sections of our Annual Report on Form 10-K for the year ended
FINANCIAL INFORMATION |
||||
|
||||
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in millions, except per share data) |
||||
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
|
$ 102.0 |
|
$ 320.3 |
Receivables, net |
|
224.7 |
|
175.6 |
Inventories |
|
617.3 |
|
534.0 |
Prepaid expenses and other current assets |
|
55.5 |
|
24.9 |
Total current assets |
|
999.5 |
|
1,054.8 |
Property, plant, and equipment, net |
|
734.7 |
|
737.6 |
Operating lease right-of-use assets |
|
163.0 |
|
193.0 |
|
|
1,823.2 |
|
1,824.7 |
Intangible assets, net |
|
224.7 |
|
257.4 |
Other assets, net |
|
24.3 |
|
39.1 |
Total assets |
|
$ 3,969.4 |
|
$ 4,106.6 |
Liabilities and Stockholders' Equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
|
$ 547.1 |
|
$ 534.9 |
Accrued expenses |
|
168.2 |
|
169.0 |
Current portion of long-term debt |
|
0.9 |
|
0.4 |
Total current liabilities |
|
716.2 |
|
704.3 |
Long-term debt |
|
1,399.9 |
|
1,396.0 |
Operating lease liabilities |
|
135.1 |
|
165.0 |
Deferred income taxes |
|
107.2 |
|
111.4 |
Other long-term liabilities |
|
58.4 |
|
65.1 |
Total liabilities |
|
2,416.8 |
|
2,441.8 |
Commitments and contingencies |
|
|
|
|
Stockholders' equity: |
|
|
|
|
Preferred stock, par value |
|
— |
|
— |
Common stock, par value |
|
0.6 |
|
0.6 |
|
|
(323.7) |
|
(234.2) |
Additional paid-in capital |
|
2,234.9 |
|
2,223.4 |
Accumulated deficit |
|
(280.7) |
|
(248.9) |
Accumulated other comprehensive loss |
|
(78.5) |
|
(76.1) |
Total stockholders' equity |
|
1,552.6 |
|
1,664.8 |
Total liabilities and stockholders' equity |
|
$ 3,969.4 |
|
$ 4,106.6 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in millions, except per share data) |
||||||||
|
|
|
|
|
||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net sales |
|
$ 839.1 |
|
$ 863.3 |
|
$ 2,448.3 |
|
$ 2,520.8 |
Cost of sales |
|
707.9 |
|
725.8 |
|
2,076.8 |
|
2,096.5 |
Gross profit |
|
131.2 |
|
137.5 |
|
371.5 |
|
424.3 |
Operating expenses: |
|
|
|
|
|
|
|
|
Selling and distribution |
|
36.0 |
|
44.5 |
|
114.4 |
|
128.9 |
General and administrative |
|
46.0 |
|
47.5 |
|
156.0 |
|
154.8 |
Amortization expense |
|
12.3 |
|
12.0 |
|
36.5 |
|
36.1 |
Asset impairment |
|
— |
|
— |
|
19.3 |
|
— |
Other operating expense (income), net |
|
5.1 |
|
(0.1) |
|
22.7 |
|
(0.3) |
Total operating expenses |
|
99.4 |
|
103.9 |
|
348.9 |
|
319.5 |
Operating income |
|
31.8 |
|
33.6 |
|
22.6 |
|
104.8 |
Other expense: |
|
|
|
|
|
|
|
|
Interest expense |
|
16.0 |
|
20.9 |
|
47.2 |
|
57.9 |
Interest income |
|
(0.1) |
|
(10.8) |
|
(4.2) |
|
(36.2) |
(Gain) loss on foreign currency exchange |
|
(1.7) |
|
3.7 |
|
3.2 |
|
0.7 |
Other expense, net |
|
21.9 |
|
6.3 |
|
16.9 |
|
9.8 |
Total other expense |
|
36.1 |
|
20.1 |
|
63.1 |
|
32.2 |
(Loss) income before income taxes |
|
(4.3) |
|
13.5 |
|
(40.5) |
|
72.6 |
Income tax (benefit) expense |
|
(0.9) |
|
3.7 |
|
(8.7) |
|
20.0 |
Net (loss) income from continuing operations |
|
(3.4) |
|
9.8 |
|
(31.8) |
|
52.6 |
Net loss from discontinued operations |
|
— |
|
(2.7) |
|
— |
|
(7.0) |
Net (loss) income |
|
$ (3.4) |
|
$ 7.1 |
|
$ (31.8) |
|
$ 45.6 |
|
|
|
|
|
|
|
|
|
Earnings (loss) per common share - basic: |
|
|
|
|
|
|
|
|
Continuing operations |
|
$ (0.07) |
|
$ 0.18 |
|
$ (0.60) |
|
$ 0.94 |
Discontinued operations |
|
— |
|
(0.05) |
|
— |
|
(0.12) |
Earnings (loss) per share basic (1) |
|
$ (0.07) |
|
$ 0.13 |
|
$ (0.60) |
|
$ 0.81 |
|
|
|
|
|
|
|
|
|
Earnings (loss) per common share - diluted: |
|
|
|
|
|
|
|
|
Continuing operations |
|
$ (0.07) |
|
$ 0.17 |
|
$ (0.60) |
|
$ 0.93 |
Discontinued operations |
|
— |
|
(0.05) |
|
— |
|
(0.12) |
Earnings (loss) per share diluted (1) |
|
$ (0.07) |
|
$ 0.13 |
|
$ (0.60) |
|
$ 0.80 |
|
|
|
|
|
|
|
|
|
Weighted average common shares: |
|
|
|
|
|
|
|
|
Basic |
|
51.9 |
|
55.9 |
|
52.7 |
|
56.1 |
Diluted |
|
51.9 |
|
56.4 |
|
52.7 |
|
56.7 |
|
(1) The sum of the individual per share amounts may not add due to rounding. |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in millions) |
||||
|
|
|
||
|
|
Nine Months Ended
|
||
|
|
2024 |
|
2023 |
Cash flows from operating activities: |
|
|
|
|
Net (loss) income |
|
$ (31.8) |
|
$ 45.6 |
Net loss from discontinued operations |
|
— |
|
(7.0) |
Net (loss) income from continuing operations |
|
(31.8) |
|
52.6 |
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating |
|
|
|
|
Depreciation and amortization |
|
109.5 |
|
105.7 |
Asset impairment |
|
19.3 |
|
— |
Stock-based compensation |
|
15.5 |
|
19.1 |
Unrealized loss (gain) on derivative contracts |
|
11.0 |
|
(1.5) |
Deferred income taxes |
|
(4.0) |
|
1.7 |
Deferred |
|
— |
|
(12.3) |
Other |
|
8.4 |
|
0.9 |
Changes in operating assets and liabilities, net of acquisitions and divestitures: |
|
|
|
|
Receivables |
|
(48.8) |
|
(5.6) |
Inventories |
|
(84.4) |
|
(32.4) |
Prepaid expenses and other assets |
|
(19.7) |
|
(1.4) |
Accounts payable |
|
7.2 |
|
(90.5) |
Accrued expenses and other liabilities |
|
(12.6) |
|
(25.3) |
Net cash (used in) provided by operating activities - continuing operations |
|
(30.4) |
|
11.0 |
Net cash used in operating activities - discontinued operations |
|
— |
|
(0.7) |
Net cash (used in) provided by operating activities |
|
(30.4) |
|
10.3 |
Cash flows from investing activities: |
|
|
|
|
Capital expenditures |
|
(91.6) |
|
(77.1) |
Proceeds from sale of fixed assets |
|
1.4 |
|
— |
Acquisitions, net of cash acquired |
|
— |
|
(102.2) |
Net cash used in investing activities - continuing operations |
|
(90.2) |
|
(179.3) |
Net cash provided by investing activities - discontinued operations |
|
— |
|
45.5 |
Net cash used in investing activities |
|
(90.2) |
|
(133.8) |
Cash flows from financing activities: |
|
|
|
|
Borrowings under Revolving Credit Facility |
|
212.5 |
|
2,692.3 |
Payments under Revolving Credit Facility |
|
(212.5) |
|
(2,537.0) |
Payments on financing lease obligations |
|
(0.6) |
|
(0.4) |
Deferred payment from acquisition of seasoned pretzel capability |
|
(4.0) |
|
— |
Repurchases of common stock |
|
(88.7) |
|
(50.0) |
Payments related to stock-based award activities |
|
(4.0) |
|
(6.2) |
Net cash (used in) provided by financing activities - continuing operations |
|
(97.3) |
|
98.7 |
Net cash (used in) provided by financing activities - discontinued operations |
|
— |
|
— |
Net cash (used in) provided by financing activities |
|
(97.3) |
|
98.7 |
Effect of exchange rate changes on cash and cash equivalents |
|
(0.4) |
|
1.5 |
Net decrease in cash and cash equivalents |
|
(218.3) |
|
(23.3) |
Cash and cash equivalents, beginning of period |
|
320.3 |
|
43.0 |
Cash and cash equivalents, end of period |
|
$ 102.0 |
|
$ 19.7 |
|
|
Nine Months Ended
|
||
|
|
2024 |
|
2023 |
Supplemental cash flow disclosures: |
|
|
|
|
Interest paid |
|
$ 69.6 |
|
$ 75.7 |
Net income taxes paid |
|
5.7 |
|
17.5 |
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
Capital expenditures incurred but not yet paid |
|
21.5 |
|
32.9 |
Right-of-use assets obtained in exchange for lease obligations |
|
3.3 |
|
40.5 |
Accrued deferred financing costs |
|
0.2 |
|
— |
Note receivable purchase price adjustment reduction |
|
— |
|
(5.1) |
Note receivable increase from paid in kind interest |
|
— |
|
3.2 |
Deferred payment from acquisition of seasoned pretzel capability |
|
— |
|
4.0 |
The following table reconciles the Company's net (loss) income from continuing operations to EBITDA and adjusted EBITDA from continuing operations, for the three and nine months ended
RECONCILIATION OF NET (LOSS) INCOME FROM CONTINUING OPERATIONS TO EBITDA AND ADJUSTED EBITDA FROM CONTINUING OPERATIONS (Unaudited, in millions) |
||||||||
|
|
|
|
|
||||
|
|
Three Months Ended September |
|
Nine Months Ended September |
||||
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net (loss) income from continuing operations (GAAP) |
|
$ (3.4) |
|
$ 9.8 |
|
$ (31.8) |
|
$ 52.6 |
Interest expense |
|
16.0 |
|
20.9 |
|
47.2 |
|
57.9 |
Interest income |
|
(0.1) |
|
(10.8) |
|
(4.2) |
|
(36.2) |
Income tax (benefit) expense |
|
(0.9) |
|
3.7 |
|
(8.7) |
|
20.0 |
Depreciation and amortization |
|
36.7 |
|
36.0 |
|
109.5 |
|
105.7 |
EBITDA from continuing operations (Non-GAAP) |
|
48.3 |
|
59.6 |
|
112.0 |
|
200.0 |
Product recalls and related costs(1) |
|
28.3 |
|
11.2 |
|
42.7 |
|
11.2 |
Mark-to-market adjustments(2) |
|
19.5 |
|
2.0 |
|
11.0 |
|
(1.5) |
Growth, reinvestment, restructuring programs & other(3) |
|
6.8 |
|
9.7 |
|
25.0 |
|
33.9 |
Acquisition, integration, divestiture, and related costs(4) |
|
0.9 |
|
4.9 |
|
6.9 |
|
13.5 |
Foreign currency (gain) loss on re-measurement of intercompany notes(5) |
|
(1.3) |
|
2.5 |
|
2.2 |
|
(0.2) |
Impairment(6) |
|
— |
|
— |
|
19.3 |
|
— |
Shareholder activism(7) |
|
— |
|
— |
|
— |
|
0.3 |
Tax indemnification(8) |
|
— |
|
— |
|
— |
|
0.3 |
Adjusted EBITDA from continuing operations (Non-GAAP) |
|
$ 102.5 |
|
$ 89.9 |
|
$ 219.1 |
|
$ 257.5 |
|
|
|
|
|
|
|
|
|
% of net sales |
|
|
|
|
|
|
|
|
Net (loss) income from continuing operations margin |
|
(0.4) % |
|
1.1 % |
|
(1.3) % |
|
2.1 % |
EBITDA from continuing operations margin |
|
5.8 % |
|
6.9 % |
|
4.6 % |
|
7.9 % |
|
|
|
|
|
|
|
|
|
% of adjusted net sales |
|
|
|
|
|
|
|
|
Adjusted EBITDA from continuing operations margin |
|
12.0 % |
|
10.4 % |
|
8.9 % |
|
10.2 % |
During the three and nine months ended
(1) |
Griddle Recall and Related Costs
On
Broth Recall and Related Costs
On |
|
|
(2) |
The Company's derivative contracts are marked-to-market each period. The non-cash unrealized changes in fair value recognized in Other expense, net within the Condensed Consolidated Statements of Operations are treated as Non-GAAP adjustments. As the contracts are settled, realized gains and losses are recognized, and only the mark-to-market impacts are treated as Non-GAAP adjustments. |
|
|
(3) |
The Company's growth, reinvestment, and restructuring activities are part of an enterprise-wide transformation to improve long-term growth and profitability for the Company. |
|
|
(4) |
Acquisition, integration, divestiture, and related costs represents costs associated with completed and potential acquisitions, the related integration of the acquisitions, completed and potential divestitures, and gains or losses on the divestiture of a business. During the three and nine months ended |
|
|
(5) |
The Company has foreign currency denominated intercompany loans and incurred foreign currency gains/losses to re-measure the loans at quarter end. These amounts are non-cash and the loans are eliminated in consolidation. |
|
|
(6) |
During the second quarter of 2024, the Company incurred |
|
|
(7) |
The Company incurred fees related to shareholder activism which include directly applicable third-party advisory and professional service fees. |
|
|
(8) |
Tax indemnification represents the non-cash write off of indemnification assets that were recorded in connection with acquisitions from prior years. These write-offs arose as a result of the related uncertain tax position being released due to the statute of limitation lapse or settlement with taxing authorities. |
The following tables reconcile the Company's adjusted net sales, adjusted cost of sales, adjusted gross profit, adjusted total operating expenses, adjusted operating income (loss), adjusted total other expense (income), adjusted income tax expense (benefit), and adjusted net income (loss) to their most directly comparable GAAP measure, for three and nine months ended
RECONCILIATION OF NON-GAAP MEASURES (Unaudited, in millions, except per share amounts) |
||||||||||||||||
|
|
|
||||||||||||||
|
|
Three Months Ended |
||||||||||||||
|
|
Net sales |
|
Cost of |
|
Gross |
|
Total |
|
Operating |
|
Total |
|
Income |
|
Net (loss) |
As reported (GAAP) |
|
$ 839.1 |
|
$ 707.9 |
|
$ 131.2 |
|
$ 99.4 |
|
$ 31.8 |
|
$ 36.1 |
|
$ (0.9) |
|
$ (3.4) |
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product recalls and related costs(1) |
|
15.3 |
|
(13.0) |
|
28.3 |
|
— |
|
28.3 |
|
— |
|
— |
|
28.3 |
Mark-to-market adjustments(2) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(19.5) |
|
— |
|
19.5 |
Growth, reinvestment, restructuring programs & other(3) |
|
— |
|
(1.7) |
|
1.7 |
|
(5.1) |
|
6.8 |
|
— |
|
— |
|
6.8 |
Acquisition, integration, divestiture, and related costs(4) |
|
— |
|
0.1 |
|
(0.1) |
|
(1.0) |
|
0.9 |
|
— |
|
— |
|
0.9 |
Foreign currency gain on re-measurement of intercompany notes(5) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
1.3 |
|
— |
|
(1.3) |
Taxes on adjusting items |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
12.1 |
|
(12.1) |
As adjusted (Non-GAAP) |
|
$ 854.4 |
|
$ 693.3 |
|
$ 161.1 |
|
$ 93.3 |
|
$ 67.8 |
|
$ 17.9 |
|
$ 11.2 |
|
$ 38.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported (% of net sales) |
|
|
|
|
|
15.6 % |
|
11.8 % |
|
3.8 % |
|
4.3 % |
|
(0.1) % |
|
(0.4) % |
As adjusted (% of adjusted net sales) |
|
|
|
|
|
18.9 % |
|
10.9 % |
|
7.9 % |
|
2.1 % |
|
1.3 % |
|
4.5 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share from continuing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (0.07) |
Adjusted diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.74 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted for net loss from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51.9 |
Diluted for adjusted net income from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52.2 |
|
|
Three Months Ended |
||||||||||||||
|
|
Net sales |
|
Cost of |
|
Gross |
|
Total |
|
Operating |
|
Total |
|
Income |
|
Net |
As reported (GAAP) |
|
$ 863.3 |
|
$ 725.8 |
|
$ 137.5 |
|
$ 103.9 |
|
$ 33.6 |
|
$ 20.1 |
|
$ 3.7 |
|
$ 9.8 |
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product recalls and related costs(1) |
|
3.0 |
|
(8.2) |
|
11.2 |
|
— |
|
11.2 |
|
— |
|
— |
|
11.2 |
Mark-to-market adjustments(2) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(2.0) |
|
— |
|
2.0 |
Growth, reinvestment, restructuring programs & other(3) |
|
— |
|
— |
|
— |
|
(9.7) |
|
9.7 |
|
— |
|
— |
|
9.7 |
Acquisition, integration, divestiture, and related costs(4) |
|
— |
|
(1.0) |
|
1.0 |
|
(3.9) |
|
4.9 |
|
— |
|
— |
|
4.9 |
Foreign currency loss on re-measurement of intercompany notes(5) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(2.5) |
|
— |
|
2.5 |
Taxes on adjusting items |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
7.7 |
|
(7.7) |
As adjusted (Non-GAAP) |
|
$ 866.3 |
|
$ 716.6 |
|
$ 149.7 |
|
$ 90.3 |
|
$ 59.4 |
|
$ 15.6 |
|
$ 11.4 |
|
$ 32.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported (% of net sales) |
|
|
|
|
|
15.9 % |
|
12.0 % |
|
3.9 % |
|
2.3 % |
|
0.4 % |
|
1.1 % |
As adjusted (% of adjusted net sales) |
|
|
|
|
|
17.3 % |
|
10.4 % |
|
6.9 % |
|
1.8 % |
|
1.3 % |
|
3.7 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share from continuing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.17 |
Adjusted diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted for net income from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56.4 |
Diluted for adjusted net income from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56.4 |
|
|
Nine Months Ended |
||||||||||||||
|
|
Net sales |
|
Cost of |
|
Gross |
|
Total |
|
Operating |
|
Total |
|
Income |
|
Net (loss) |
As reported (GAAP) |
|
$ 2,448.3 |
|
$ 2,076.8 |
|
$ 371.5 |
|
$ 348.9 |
|
$ 22.6 |
|
$ 63.1 |
|
$ (8.7) |
|
$ (31.8) |
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product recalls and related costs(1) |
|
17.6 |
|
(25.1) |
|
42.7 |
|
— |
|
42.7 |
|
— |
|
— |
|
42.7 |
Mark-to-market adjustments(2) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(11.0) |
|
— |
|
11.0 |
Growth, reinvestment, restructuring programs & other(3) |
|
— |
|
(1.7) |
|
1.7 |
|
(23.3) |
|
25.0 |
|
— |
|
— |
|
25.0 |
Acquisition, integration, divestiture, and related costs(4) |
|
— |
|
(2.0) |
|
2.0 |
|
(4.9) |
|
6.9 |
|
— |
|
— |
|
6.9 |
Foreign currency loss on re-measurement of intercompany notes(5) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(2.2) |
|
— |
|
2.2 |
Impairment(6) |
|
— |
|
— |
|
— |
|
(19.3) |
|
19.3 |
|
— |
|
— |
|
19.3 |
Taxes on adjusting items |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
23.4 |
|
(23.4) |
As adjusted (Non-GAAP) |
|
$ 2,465.9 |
|
$ 2,048.0 |
|
$ 417.9 |
|
$ 301.4 |
|
$ 116.5 |
|
$ 49.9 |
|
$ 14.7 |
|
$ 51.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported (% of net sales) |
|
|
|
|
|
15.2 % |
|
14.3 % |
|
0.9 % |
|
2.6 % |
|
(0.4) % |
|
(1.3) % |
As adjusted (% of adjusted net sales) |
|
|
|
|
|
16.9 % |
|
12.2 % |
|
4.7 % |
|
2.0 % |
|
0.6 % |
|
2.1 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share from continuing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (0.60) |
Adjusted diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.98 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted for net loss from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52.7 |
Diluted for adjusted net income from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.0 |
|
|
Nine Months Ended |
||||||||||||||
|
|
Net sales |
|
Cost of |
|
Gross |
|
Total |
|
Operating |
|
Total |
|
Income |
|
Net |
As reported (GAAP) |
|
$ 2,520.8 |
|
$ 2,096.5 |
|
$ 424.3 |
|
$ 319.5 |
|
$ 104.8 |
|
$ 32.2 |
|
$ 20.0 |
|
$ 52.6 |
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product recalls and related costs(1) |
|
3.0 |
|
(8.2) |
|
11.2 |
|
— |
|
11.2 |
|
— |
|
— |
|
11.2 |
Mark-to-market adjustments(2) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
1.5 |
|
— |
|
(1.5) |
Growth, reinvestment, restructuring programs & other(3) |
|
— |
|
— |
|
— |
|
(33.9) |
|
33.9 |
|
— |
|
— |
|
33.9 |
Acquisition, integration, divestiture, and related costs(4) |
|
— |
|
(1.0) |
|
1.0 |
|
(12.5) |
|
13.5 |
|
— |
|
— |
|
13.5 |
Foreign currency gain on re-measurement of intercompany notes(5) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
0.2 |
|
— |
|
(0.2) |
Shareholder activism(7) |
|
— |
|
— |
|
— |
|
(0.3) |
|
0.3 |
|
— |
|
— |
|
0.3 |
Tax indemnification(8) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(0.3) |
|
— |
|
0.3 |
Taxes on adjusting items |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
13.7 |
|
(13.7) |
As adjusted (Non-GAAP) |
|
$ 2,523.8 |
|
$ 2,087.3 |
|
$ 436.5 |
|
$ 272.8 |
|
$ 163.7 |
|
$ 33.6 |
|
$ 33.7 |
|
$ 96.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported (% of net sales) |
|
|
|
|
|
16.8 % |
|
12.7 % |
|
4.2 % |
|
1.3 % |
|
0.8 % |
|
2.1 % |
As adjusted (% of adjusted net sales) |
|
|
|
|
|
17.3 % |
|
10.8 % |
|
6.5 % |
|
1.3 % |
|
1.3 % |
|
3.8 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share from continuing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.93 |
Adjusted diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.70 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted for net income from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56.7 |
Diluted for adjusted net income from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56.7 |
RECONCILIATION OF (Unaudited, in millions)
|
||||
|
|
|
||
|
|
Nine Months Ended
|
||
|
|
2024 |
|
2023 |
|
|
|
||
Cash flow (used in) provided by operating activities from continuing operations |
|
$ (30.4) |
|
$ 11.0 |
Less: Capital expenditures |
|
(91.6) |
|
(77.1) |
Free cash flow from continuing operations |
|
$ (122.0) |
|
$ (66.1) |
View original content:https://www.prnewswire.com/news-releases/treehouse-foods-inc-reports-third-quarter-2024-results-302301831.html
SOURCE